Showing metabocard for MLCL(0:0/10:0/23:1(9Z)/25:1(9Z)) (MMDBc0056703)
| Record Information | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Version | 1.0 | ||||||||||||
| Status | Detected and Quantified | ||||||||||||
| Creation Date | 2022-07-07 21:59:01 UTC | ||||||||||||
| Update Date | 2022-08-14 03:09:44 UTC | ||||||||||||
| Metabolite ID | MMDBc0056703 | ||||||||||||
| Metabolite Identification | |||||||||||||
| Common Name | MLCL(0:0/10:0/23:1(9Z)/25:1(9Z)) | ||||||||||||
| Description | MLCL(0:0/10:0/23:1(9Z)/25:1(9Z)) is a monolysocardiolipin (MLCL). Monolysocardiolipins have three fatty acid tails, instead of the usual two. MLCL(0:0/10:0/23:1(9Z)/25:1(9Z)) contains no chain at the C1 position, one decanoyl chain at the C2 position, one 9Z-tricosanoyl chain at the C3 position, one 9Z-pentacosenoyl chain at the C4 position. MLCL is present in eukaryotes as part of the metabolic cycle of mitochondrial lipids. Removal of one acyl chain from a cardiolipin results in generation of monolysocardiolipin (MLCL). MLCL has been used as an intermediate in the synthesis of spin-labeled CL to study the interaction of CL with mitochondrial enzymes. Because a role for MLCL has been suggested in apoptosis, this molecule has been used to study its interaction with various enzymes involved in lipid remodeling and apoptosis. There are two species of monolysocardiolipins, 1-MLCL which is missing a fatty acid in position R1 the and 2-MLCL which is missing a fatty acid in position R4. | ||||||||||||
| Structure |  | ||||||||||||
| Synonyms | Not Available | ||||||||||||
| Molecular Formula | C67H128O16P2 | ||||||||||||
| Average Mass | 1251.693 | ||||||||||||
| Monoisotopic Mass | 1250.867762038 | ||||||||||||
| IUPAC Name | Not Available | ||||||||||||
| Traditional Name | Not Available | ||||||||||||
| CAS Registry Number | Not Available | ||||||||||||
| SMILES | Not Available | ||||||||||||
| InChI Identifier | InChI=1S/C67H128O16P2/c1-4-7-10-13-16-18-20-22-24-26-28-30-31-33-35-37-39-41-43-46-49-52-55-67(72)83-64(59-77-65(70)53-50-47-45-42-40-38-36-34-32-29-27-25-23-21-19-17-14-11-8-5-2)61-81-85(75,76)79-58-62(69)57-78-84(73,74)80-60-63(56-68)82-66(71)54-51-48-44-15-12-9-6-3/h34-37,62-64,68-69H,4-33,38-61H2,1-3H3,(H,73,74)(H,75,76)/b36-34-,37-35-/t62-,63-,64-/m1/s1 | ||||||||||||
| InChI Key | YERKGBFNLMHDPI-GGRFNBPCSA-N | ||||||||||||
| Chemical Taxonomy | |||||||||||||
| Functional Ontology | |||||||||||||
| Not Available | |||||||||||||
| Physical Properties | |||||||||||||
| State | Expected Solid | ||||||||||||
| Predicted Properties | Not Available | ||||||||||||
| Spectra | |||||||||||||
| Chromatographic Retention Times and Retention Indices | |||||||||||||
| Retention Times | Not Available | ||||||||||||
| Retention Indices | Not Available | ||||||||||||
| Chromatographic Retention Times and Retention Indices | |||||||||||||
| Retention Times | Not Available | ||||||||||||
| Retention Indices | Not Available | ||||||||||||
| Biological Properties | |||||||||||||
| Cellular Locations | Not Available | ||||||||||||
| Biospecimen Locations | Not Available | ||||||||||||
| Tissue Locations | Not Available | ||||||||||||
| Associated OMIM IDs | |||||||||||||
| Human Proteins and Enzymes | |||||||||||||
| |||||||||||||
| Human Pathways | |||||||||||||
| Pathways |
| ||||||||||||
| Microbial Pathways | |||||||||||||
| Pathways | Not Available | ||||||||||||
| Metabolic Reactions | |||||||||||||
Reactions This table shows at most 20 reactions. For the full list of associated reactions: See All Associated Reactions
| |||||||||||||
| Health Effects and Bioactivity | |||||||||||||
| |||||||||||||
| Microbial Sources | |||||||||||||
| |||||||||||||
| Exposure Sources | |||||||||||||
| Other Exposures |
| ||||||||||||
| Host Biospecimen and Location | |||||||||||||
| |||||||||||||
| External Links | |||||||||||||
| External Links | Not Available | ||||||||||||
| General References | |||||||||||||
| |||||||||||||